Valuation: Astal Laboratories Limited

Market Cap 3.05B 31.63M 28.1M 26.28M 23.94M 45.08M 45.7M 318M 123M 1.55B 119M 116M 4.98B P/E 2025
9.45x
P/E 2026 8.37x
Enterprise Value 3.54B 36.74M 32.64M 30.52M 27.81M 52.36M 53.08M 369M 143M 1.8B 138M 135M 5.79B EV / Sales 2025
1.36x
EV / Sales 2026 1.31x
Free-Float
41%
Yield 2025 *
-
Yield 2026 -
1 day-1.93%
1 week-0.66%
Current month-1.93%
1 month-10.72%
3 months-21.01%
6 months+0.06%
Current year-19.93%
1 week 68
Extreme 68
72
1 month 62.8
Extreme 62.8
80.35
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 14/07/2023
Director TitleAgeSince
Director/Board Member 56 17/08/2023
Director/Board Member 62 -
Director/Board Member - 07/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-0.66%-16.23%+116.97% 32.39M
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.91%+34.28%+39.35% 335B
-1.58%+0.39%+17.92%+25.77% 273B
-2.02%-3.20%+7.60%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average -1.46%-0.80%+25.70%+63.30% 376.39B
Weighted average by Cap. -1.25%-1.57%+32.51%+69.18%

Financials

2025 2026
Net sales 637M 6.61M 5.87M 5.49M 5M 9.42M 9.55M 66.44M 25.72M 324M 24.82M 24.28M 1.04B 2.49B 25.82M 22.94M 21.45M 19.55M 36.8M 37.31M 259M 100M 1.27B 96.96M 94.86M 4.07B
Net income 89.25M 927K 823K 770K 702K 1.32M 1.34M 9.32M 3.61M 45.46M 3.48M 3.4M 146M 147M 1.53M 1.36M 1.27M 1.16M 2.18M 2.21M 15.35M 5.94M 74.91M 5.74M 5.61M 241M
Net Debt 115M 1.2M 1.06M 995K 907K 1.71M 1.73M 12.04M 4.66M 58.76M 4.5M 4.4M 189M 492M 5.11M 4.54M 4.24M 3.87M 7.28M 7.38M 51.34M 19.87M 251M 19.18M 18.77M 805M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
22
Date Price Change Volume
01/10/26 ₹69.54 -1.93% 2,708
30/09/26 ₹70.91 +1.81% 5,759
29/09/26 ₹69.65 -1.92% 7,819
28/09/26 ₹71.01 -0.85% 14,222
25/09/26 ₹71.62 +2.31% 4,531
  1. Stock Market
  2. Stocks
  3. MACINTR Stock